Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ruozi

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Tissue Barriers|May 4, 2016
Nanoparticle transport across the blood brain barrierAndreas M Grabrucker, Barbara Ruozi, Daniela Belletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2022
Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic XenograftsRebecca Voltan, Paola Secchiero, Barbara Ruozi, et al.
International Journal of Pharmaceutics|May 4, 2011
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomesDaniela Belletti, Giovanni Riva, Giovanni Tosi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenograftsRebecca Voltan, Paola Secchiero, Barbara Ruozi, et al.
Molecules (Basel, Switzerland)|October 14, 2020
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme FunctionJason Thomas Duskey, Federica da Ros, Ilaria Ottonelli, et al.
Nanomedicine (London, England)|September 30, 2010
Immunoliposomal systems targeting primary effusion lymphoma: in vitro studyBarbara Ruozi, Giovanni Riva, Daniela Belletti, et al.
International Journal of Pharmaceutics|June 9, 2009
Collagen-based modified membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferationBarbara Ruozi, Bruna Parma, Maria Antonietta Croce, et al.
Pharmaceutics|April 16, 2020
Lipid Nanoparticle Inclusion Prevents Capsaicin-Induced TRPV1 DefunctionalizationCarmelo Puglia, Debora Santonocito, Angela Bonaccorso, et al.
Nanoscale|November 24, 2025
Drug delivery systems for mitochondrial targetingSofia Tagliavini, Mara Filippini, Alessandro Anderlini, et al.
Plos One|March 31, 2011
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesAndreas M Grabrucker, Craig C Garner, Tobias M Boeckers, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Tissue Barriers|May 4, 2016
Nanoparticle transport across the blood brain barrierAndreas M Grabrucker, Barbara Ruozi, Daniela Belletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2022
Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic XenograftsRebecca Voltan, Paola Secchiero, Barbara Ruozi, et al.
International Journal of Pharmaceutics|May 4, 2011
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomesDaniela Belletti, Giovanni Riva, Giovanni Tosi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenograftsRebecca Voltan, Paola Secchiero, Barbara Ruozi, et al.
Molecules (Basel, Switzerland)|October 14, 2020
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme FunctionJason Thomas Duskey, Federica da Ros, Ilaria Ottonelli, et al.
Nanomedicine (London, England)|September 30, 2010
Immunoliposomal systems targeting primary effusion lymphoma: in vitro studyBarbara Ruozi, Giovanni Riva, Daniela Belletti, et al.
International Journal of Pharmaceutics|June 9, 2009
Collagen-based modified membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferationBarbara Ruozi, Bruna Parma, Maria Antonietta Croce, et al.
Pharmaceutics|April 16, 2020
Lipid Nanoparticle Inclusion Prevents Capsaicin-Induced TRPV1 DefunctionalizationCarmelo Puglia, Debora Santonocito, Angela Bonaccorso, et al.
Nanoscale|November 24, 2025
Drug delivery systems for mitochondrial targetingSofia Tagliavini, Mara Filippini, Alessandro Anderlini, et al.
Plos One|March 31, 2011
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesAndreas M Grabrucker, Craig C Garner, Tobias M Boeckers, et al.
Pageof 11